(Press-News.org) There’s been a significant rise in the use of low and alcohol-free drinks to curb alcohol intake among ‘risky drinkers’ over the past 5 years in England, Wales, and Scotland, finds research published in the open access journal BMJ Public Health.
The proportion of those using them to make serious attempts to cut down their alcohol intake rose from 35% in 2020 to 44% in 2024, while those using them in any attempt to cut down increased from 26% to 39%.
The trends were especially noticeable among the over 65s, while women and the relatively well off were more likely to consume these drinks than men and the most economically disadvantaged, the findings indicate.
The sales and availability of low and alcohol-free drinks have risen sharply in the UK since 2020, and the UK government promotes the substitution of standard alcoholic drinks with these alternatives as a harm reduction tool, explain the researchers.
But it’s not clear to what extent the increasing supply of low and alcohol-free drinks has contributed to reduction attempts, particularly among those who drink more heavily.
In a bid to find out, the researchers drew on data collected in Great Britain between October 2020 and August 2024 as part of the Smoking and Alcohol Toolkit Study, which collects monthly data on adults’ sociodemographic, smoking, and drinking characteristics.
The sample was limited to those drinking at increasing and higher-risk levels, defined as an Alcohol Use Disorders Identification Test -Consumption (AUDIT-C) score of 5 or more, and who had tried to cut down their alcohol consumption in the previous year.
They were asked if they had used low/alcohol-free drinks and which, of a variety of evidence-based support options, they had used in their attempts to curb their alcohol intake.
The final analysis included 9397 people, whose average age was 46. It showed that the proportion of those reporting the use of low and alcohol-free drinks to reduce their alcohol consumption increased significantly between 2020 and 2024..
The proportion of those using these alternatives to make serious attempts to curb their drinking rose by 9%, from 35% to 44%, and by 14%, from 26% to 39%, among those making any attempt to cut down.
Noticeably, the proportion of older adults (65+) using low and alcohol-free drinks was lower than young and middle-aged adults to start with, but rose more steeply over time.
But the proportion of those using neither these alternatives nor evidence-based approaches, such as behavioural support or drug treatment, fell. And the proportion using evidence-based options either alone or in combination with low or alcohol-free drinks remained low at around 10%, the responses showed.
This is an observational study, which only assessed trends in self-reported use of low and alcohol-free drinks for alcohol reduction attempts and, therefore, can’t make any assumptions about the effectiveness of these drinks in actually reducing alcohol consumption, emphasise the researchers.
Some respondents may also have understood the term ‘alcohol-free’ to mean soft drinks such as kombucha or flavoured sodas, they add.
“The rise in the prevalence of alcohol-free/low alcohol use in cut-down attempts in Great Britain may be driven by greater availability of alcohol-free/low alcohol drinks in pubs or increased marketing, such as the partnership between the charity organising the Dry January campaign and alcohol-free drink producers, which started in 2022,” suggest the researchers.
“It is also possible that the observed changes are consumer-driven, i.e. that people’s interest in alternatives to standard strength alcoholic drinks is growing, and the market is responding to this demand,” they add.
“In any case, it is vital for future research to establish whether alcohol-free/low alcohol drinks are an effective tool to reduce alcohol consumption…or whether people consume [these] drinks in addition to standard alcoholic drinks, therefore resulting in no change of alcohol consumption,” they point out.
And they highlight: “The socioeconomic divide is potentially concerning because alcohol-related harm is disproportionately experienced by people who are less advantaged. If alcohol-free/low alcohol drinks are shown to be effective for harm reduction, it will be vital to develop interventions targeted at people with less advantaged socioeconomic positions to reduce health inequalities.”
END
Significant rise in use of low/alcohol-free drinks among ‘risky’ UK drinkers in past 5 years
Use rose by 9% in serious attempts to cut down and by 13% in any attempt to curb intake; trends especially noticeable among over 65s, women, and relatively well off
2025-09-23
ELSE PRESS RELEASES FROM THIS DATE:
Regular exercise ‘rewires’ heart-control nerves differently on left and right side, study finds
2025-09-23
Frequent exercise doesn’t just strengthen the heart – it also changes the nerves that control it, according to new research which could guide more targeted and effective care for common heart problems.
The study, led by the University of Bristol (UK), shows for the first time that moderate aerobic training reshapes nerves that drive the heart, and affects them on each side of the heart differently. The research is published in the journal Autonomic Neuroscience today (Wednesday, 24 September).
Findings ...
Centenary of the birth of IVF pioneer Sir Robert Edwards
2025-09-23
Saturday 27th September marks the centenary of the birth of Sir Robert Edwards, who with colleagues Patrick Steptoe and Jean Purdy oversaw the conception and birth of the world’s first IVF baby in 1978.(1) It was a breakthrough in reproductive medicine which would bring immeasurable benefits to people with infertility and whose demographic importance today is greater than ever.
Now, from various reports published by this journal, we can confidently say that the global impact of IVF continues to grow in terms of children conceived and the extent of its use. There are few causes of infertility which today are not amenable to treatment while ...
New multi-registry study highlights ocrelizumab’s superior relapse control in multiple sclerosis
2025-09-23
(Barcelona, Spain, Wednesday, 24 September 2025) New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses compared with fingolimod, natalizumab, and alemtuzumab.1
Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, was evaluated using real-world data from three large MS registries: MSBase, OFSEP, and the Danish MS Registry. The analysis compared ocrelizumab-treated patients ...
Wonhwa Cho to receive Biophysical Society’s 2026 Award in the Biophysics of Health and Disease
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce that Wonhwa Cho, of the University of Illinois Chicago, USA, has been named the recipient of the 2026 BPS Award in the Biophysics of Health and Disease. Cho will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Cho will be recognized for mechanistic elucidation of lipid-protein interactions foundational to lipid-targeted drug discovery.
“Wonhwa has pioneered new and innovative experimental approaches to overcome obstacles ...
Future generations: NSF-funded project explores how nanoplastics are transmitted to offspring
2025-09-23
You can’t see nanoplastics with the naked eye, but they’re everywhere — including your body.
Tinier than the better-known microplastics, these plastic particles range from one nanometer to one micrometer in size; a human hair, by comparison, is about 100 micrometers thick.
“Nanoplastics are present in drinking water, food and the air, and have been detected in both tap water and bottled water,” explained Binghamton University Assistant Professor of Chemistry Huiyuan Guo. “They are widely detected in the environment.”
Guo and Associate Professor of Biological Sciences ...
Erdinc Sezgin to receive 2026 Early Independent Career Award
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce that Erdinc Sezgin, of SciLifeLab, Karolinska Institutet, Sweden, has been named the recipient of the 2026 Early Independent Career Award. Sezgin will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Sezgin will be recognized for combining chemistry, physics, biology and computer science to gain fundamental and translational insights into how the biophysics of cells affect health and disease.
“I am delighted that Erdinc ...
Charles L. Brooks III to receive 2026 Klaus Schulten and Zaida Luthey-Schulten Computational Biophysics Lecture Award
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce that Charles L. Brooks III, of the University of Michigan, USA, has been named the recipient of the 2026 Klaus Schulten and Zaida Luthey-Schulten Computational Biophysics Lecture Award. Brooks will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Brooks will be recognized for his pioneering work in protein folding, free energy methods and service to the field of biophysics.
“Charles’ work leads the field not only in methodological ...
Jie Xiao to receive 2026 Carolyn Cohen Innovation Award
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce that Jie Xiao, of the Johns Hopkins School of Medicine, USA, will receive the 2026 Carolyn Cohen Innovation Award. Xiao will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Xiao will be recognized for her pioneering work in developing single-molecule imaging and analysis approaches to investigate the molecular and cellular mechanisms of bacterial cell division and transcription.
“Jie’s ...
Elizabeth Hinde and Jorge Alegre-Cebollada to receive 2026 Michael and Kate Bárány Award
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce Elizabeth Hinde, of the School of Physics, University of Melbourne, Australia and Jorge Alegre-Cebollada, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Spain, have been named recipients of the 2026 Michael and Kate Bárány Award. Hinde and Alegre-Cebollada will be honored at Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Hinde will be recognized for the creative application of physical principles to biological systems, particularly in the development of spatiotemporal correlation spectroscopy ...
Nuria Assa-Munt to receive 2026 Rosalba Kampman Distinguished Service Award
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce that Nuria Assa-Munt, of the Center for Scientific Review, National Institutes of Health (retired), USA has been named the recipient of the Society’s 2026 Rosalba Kampman Distinguished Service Award. Assa-Munt will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Assa-Munt is being recognized for her tireless efforts and exemplary leadership in setting the highest standards for NIH reviews, advancing biophysics research, and training the next generation of scientists.
“Nuria, through her two decades of federal service, dedicated herself to ...
LAST 30 PRESS RELEASES:
National Multiple Sclerosis Society awards Dr. Manuel A. Friese the 2025 Barancik Prize for Innovation in MS Research
PBM profits obscured by mergers and accounting practices, USC Schaeffer white paper shows
Breath carries clues to gut microbiome health
New study links altered cellular states to brain structure
Palaeontology: Ancient giant kangaroos could hop to it when they needed to
Decoded: How cancer cells protect themselves from the immune system
ISSCR develops roadmap to accelerate pluripotent stem cell-derived therapies to patients
New study shows gut microbiota directly regulates intestinal stem cell aging
Leading cancer deaths in people younger than 50 years
Rural hospital bypass by patients with commercial health insurance
Jumping giants: Fossils show giant prehistoric kangaroos could still hop
Missing Medicare data alters hospital penalties, study finds
Experimental therapy targets cancer’s bodyguards, turning foe to friend to eliminate tumors
Discovery illuminates how inflammatory bowel disease promotes colorectal cancer
Quality and quantity? The clinical significance of myosteatosis in various liver diseases
Expert consensus on clinical applications of fecal microbiota transplantation for chronic liver disease (2025 edition)
Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor fo
New imaging technology detects early signs of heart disease through the skin
Resurrected ancient enzyme offers new window into early Earth and the search for life beyond it
People with obesity may have a higher risk of dementia
Insilico Medicine launches science MMAI gym to train frontier LLMs into pharmaceutical-grade scientific engines
5 pre-conference symposia scheduled ahead of International Stroke Conference 2026
To explain or not? Need for AI transparency depends on user expectation
Global prevalence, temporal trends, and associated mortality of bacterial infections in patients with liver cirrhosis
Scientists discover why some Central Pacific El Niños die quickly while others linger for years
CNU research explains how boosting consumer trust unlocks the $4 billion market for retired EV batteries
Reimagining proprioception: when biology meets technology
Chungnam National University study finds climate adaptation can ease migration pressures in Africa
A cigarette compound-induced tumor microenvironment promotes sorafenib resistance in hepatocellular carcinoma via the 14-3-3η-modified tumor-associated proteome
Brain network disorders study provides insights into the role of molecular chaperones in neurodegenerative diseases
[Press-News.org] Significant rise in use of low/alcohol-free drinks among ‘risky’ UK drinkers in past 5 yearsUse rose by 9% in serious attempts to cut down and by 13% in any attempt to curb intake; trends especially noticeable among over 65s, women, and relatively well off